Navigation Links
University of Louisville researchers sign global licensing agreement
Date:10/30/2013

plant "conditioning," which includes radiation and chemotherapy to suppress the bone marrow so the donor's stem cells have more space to grow in the recipient's body.

One day after the kidney is transplanted into the recipient, the donor stem cells engraft in the marrow of the recipient and give rise to other specialized blood cells, like immune cells. The goal is to create an environment where two bone marrow systems co-exist and function in one person. Following transplantation, the recipient takes anti-rejection drugs which are decreased over time with the goal to stop a year after the transplant.

In 1998, Ildstad was one of the first recruits to the University of Louisville under the Commonwealth's Bucks for Brains initiative, advanced by former Gov. Paul Patton. As the Jewish Hospital Distinguished Chair in Transplantation Research, Ildstad brought a team of 25 families from Philadelphia to join the University of Louisville. In the following years the team has continued to examine the facilitating cell (FCRx) platform technology for the treatment of kidney transplant recipients as well as considering its potential for the treatment of red blood cell disorders, inherited metabolic storage disorders of childhood, and autoimmune disorders.

"Being a transplant recipient is not easy. In order to prevent rejection, current transplant recipients must take multiple pills a day for the rest of their lives. These immunosuppressive medications come with serious side effects with prolonged use including high blood pressure, diabetes, infection, heart disease and cancer, as well as direct damaging effects to the organ transplant," Ildstad said. "This new approach would potentially offer a better quality of life and fewer health risks for transplant recipients."

"In 1997, the University of Louisville was given a mandate to become a premier metropolitan research university that transforms the lives of the people of Kentucky and beyond," sa
'/>"/>

Contact: Gary Mans
gary.mans@louisville.edu
502-852-7504
University of Louisville
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Queens University in €6m bid to find new Cystic Fibrosis treatments
2. Clemson University study points to possible treatment for brain disorders
3. University of Utah researchers receive NIH Directors New Innovator Award
4. Technical Program Announced for TSensors (Trillion Sensor) Summit at Stanford University for October 22-25, 2013
5. University of Maryland researchers studying vaccine to prevent potential bird flu pandemic
6. University of Tennessee professor and student develop device to detect biodiesel contamination
7. University of Hawaii Cancer Center researchers discovery
8. Montana State University researchers highlight bears use of Banff highway crossings
9. Scientists at Mainz University decode mechanisms of cell orientation in the brain
10. Oxford University Press to publish BioScience journal from 2014
11. University of Alberta scientists get dirty at the Robson Glacier
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
University of Louisville researchers sign global licensing agreement
(Date:7/9/2015)... 07, 2015 Research ... of the "Biometrics for Banking; Market & ... report to their offering. The adoption ... this growth and the forecast is that by ... for companies involved in delivering biometric systems to ...
(Date:7/8/2015)...  Trovagene, Inc. (NASDAQ: TROV ), a ... launch of a study that aims to determine ... technology for predicting response to treatment in advanced ... the novel immunotherapy agents Yervoy® (ipilumumab), a CTLA-4 ... 50-patient study will be led by researchers at ...
(Date:7/2/2015)... DUBLIN , June 25, 2015 ... has announced the addition of the "Natural ... Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image ... to their offering. The key vendors ... Google, HP, IBM Corporation, Microsoft Corporation, NetBase Solutions, ...
Breaking Biology News(10 mins):Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2
... University have created a blueprint for artificial cells that ... they mimic and could one day be used to ... with the question of whether an artificial version of ... could be designed as a potential power source. ...
... investigating the rice genome has been developed by researchers ... plant pathology. The inexpensive, publicly-available rice DNA microarray covers ... Details are published this week in the open-access journal ... as humans or rice plants, each cell type express ...
... are central to understanding male infertility and could be ... according to a paper published by the journal ... how proteomics, a relatively new field focusing on the ... applied to infertility, helping identify which proteins in sperm ...
Cached Biology News:Researchers design artificial cells that could power medical implants 2Proteins in sperm unlock understanding of male infertility says new study 2
(Date:8/3/2015)... ... August 03, 2015 , ... Nine field days to promote practices that ... by the Soil Health Partnership , the field days will demonstrate how changing ... increasing farm productivity and income. , Brent Bible has practiced no-till farming and planted ...
(Date:8/3/2015)... GERMANTOWN, Md. , Aug. 3, 2015   ... it will release first half and second quarter 2015 ... 10 th , 2015.  The Company will host a ... results and provide a general business update. ... (Domestic US) and 1-412-902-4262 (International), and asking to join ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... pumps to its comprehensive line of analytical laboratory equipment. With optimized features, such ... pumps provide a chemically resistant and maintenance-free solution for a broad range of ...
(Date:7/31/2015)... 2015 China Cord Blood Corporation (NYSE: CO) ... leading provider of cord blood collection, laboratory testing, hematopoietic ... announced that the Company has filed its Annual Report ... Commission. The filed Form 20-F includes audited financial statements ... Form 20-F can be accessed by visiting the U.S. ...
Breaking Biology Technology:Soil Health Field Days Kick Off Throughout Midwest 2Soil Health Field Days Kick Off Throughout Midwest 3Intrexon to Announce First Half and Second Quarter 2015 Financial Results and Host Conference Call on August 10th 2Sterlitech Launches New Line of Vacuum Pumps 2China Cord Blood Corporation Files Its Annual Report on Form 20-F 2
... , , , ... (OTC Bulletin Board: IAGX), an innovator of scientifically tested, natural-based, ... of Research & Development, was interviewed by Pimm Fox on ... the bioceutical business of Imagenetix outlining the science behind its ...
... to also Raise $7.5 Million in Non-Dilutive Financing from, ... 17 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ: VSGN ; TSX:VAS) ... a definitive agreement, subject to shareholder and regulatory approvals, whereby ... and merger to continue as a publicly-traded entity to be ...
... , , SAN DIEGO, ... Ip, Chair Professor of the Department of Biochemistry and Director ... Science and Technology (HKUST), has joined their scientific advisory board. ... and recipient of China,s highest honor in the natural sciences, ...
Cached Biology Technology:Imagenetix, Inc. Announces Interview With Bloomberg Radio 2Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company 2Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company 3Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company 4Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company 5Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company 6Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company 7Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company 8Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company 9Professor Nancy Ip Joins aTyr Pharma's Scientific Advisory Board 2
... is the experimental process of determining the ... automated DNA Sequencing is based on Sangers ... which allows cycle sequencing reactions. The resulting ... a capillary instrument controlled by a computer ...
...
High-throughput DNA sequencing of any library. Just give us your transformation mixture, and we'll do the rest. ABI 3730xl's yield the longest read lengths available. LIMS tracking utilizing Geospiza...
... sequencing of plasmids and PCR amplicons. ... high performance sequencing pipeline which processes ... day. The key benefits we offer ... rapid turnaround, high sequencing pass rates ...
Biology Products: